Sapphire Medical Foundations — UK Medical Cannabis

Sapphire Medical Foundations occupies a distinct position in the UK medical cannabis landscape: as a research-led clinic with strong academic credentials, they place significant emphasis on evidence generation alongside patient care. Their higher consultation fee reflects a more comprehensive initial assessment and a commitment to contributing to the clinical evidence base through their patient registry.

Is Sapphire Medical Legitimate?

Yes. Sapphire Medical Foundations is a legitimate UK specialist clinic operating fully within the legal framework for Schedule 2 cannabis-based medicines. All prescribers are GMC-registered specialist clinicians. Sapphire is one of the most academically credentialled cannabis clinics in the UK — they run the UK Medical Cannabis Registry, a formal research programme conducted in collaboration with academic partners, and their clinicians include specialists with NHS and university appointments.

Sapphire prescriptions are issued under the Misuse of Drugs Regulations 2001 (Schedule 2) and dispensed by licensed UK pharmacies. If you want to verify your prescriber, the GMC register is publicly searchable at gmc-uk.org. The research programme and academic profile of Sapphire make it one of the most transparent and verifiable clinics operating in the UK market.

Sapphire Medical Review — Strengths and Limitations

Strengths

• Research-led and academically credentialled — operates the UK Medical Cannabis Registry with academic partners
• Most comprehensive initial assessment — consultations typically 45 to 60 minutes, the longest in the market
• Broad specialist team — covers complex neurological conditions including paediatric epilepsy
• High clinical rigour — appropriate for patients with complex or rare conditions where depth of assessment matters
• Contributes to UK evidence — patients participate in a formal outcomes registry (voluntary)

Limitations

• Higher initial fee — from £150, higher than most other established UK clinics
• Longer wait times — appointments typically 5 to 10 working days, reflecting more thorough scheduling
• More preparation required — the comprehensive assessment means more documentation needs to be gathered in advance

About Sapphire Medical Foundations

Sapphire Medical was established by a group of UK clinicians and researchers with the explicit dual goal of providing high-quality patient care and generating rigorous real-world evidence about cannabis-based medicines. They operate the UK Medical Cannabis Registry, one of the largest observational datasets of cannabis-based medicine outcomes in the country, in collaboration with academic research partners.

This research orientation means that patients at Sapphire are contributing to the UK evidence base for cannabis-based medicines — a factor that some patients find meaningful. The clinic works with a team of specialist clinicians across a broad range of relevant disciplines.

Sapphire Medical Conditions — What They Treat

Sapphire Medical Foundations covers a broad range of conditions, with particular strength in neurological and complex presentations that other clinics may decline. The full list of conditions assessed includes:

• Chronic pain — including neuropathic pain, fibromyalgia, and rheumatoid arthritis
• Multiple sclerosis — including Sativex (nabiximols) prescribing for spasticity
• Epilepsy — including rare paediatric syndromes; one of very few UK clinics with paediatric cannabis expertise
• PTSD and anxiety disorders
• Sleep disorders and insomnia
• Cancer-related symptoms — including pain, nausea, and appetite
• Tourette syndrome
• Migraines and cluster headaches
• Endometriosis and chronic pelvic pain
• Other neurological, inflammatory, and complex conditions — assessed on clinical merit

Sapphire Medical Eligibility — Who Can Book?

Sapphire assesses eligibility on a clinical basis rather than against a fixed approved-indications list. The core eligibility criteria are:

• UK residency: You must be a UK resident aged 18 or over (paediatric exceptions exist for epilepsy).
• Confirmed diagnosis: A formal diagnosis of a qualifying condition, supported by medical records.
• Treatment history: Evidence that at least two appropriate conventional treatments have been tried without adequate benefit. The number and type of treatments required varies by condition — neurological conditions typically require more documented treatment resistance.
• Specialist documentation: Where relevant (epilepsy, MS, cancer), letters from your neurologist, oncologist, or relevant NHS specialist strengthen your eligibility assessment significantly.
• Absence of contraindications: Active psychosis, a history of cannabis-induced psychosis, and certain other clinical factors may preclude prescribing.

Sapphire's pre-consultation screening is more comprehensive than most clinics. Completing their eligibility assessment thoroughly before booking is important.

Sapphire Medical Card — Patient Identification

Sapphire Medical issues a patient identification card to patients with an active prescription. The Sapphire medical cannabis card serves as documentation that you are a registered patient of a UK licensed medical cannabis clinic with a valid Schedule 2 prescription.

The card is not a legal requirement under UK law — it does not override the Misuse of Drugs Regulations or any roadside testing powers — but it provides contextual information that can be useful in the following situations:

• Roadside stops: If stopped by police and carrying your prescribed cannabis-based medicine, the card documents your patient status and the clinic issuing your prescription. Officers may contact the clinic to verify. Note: possession of a card does not exempt you from drug driving laws — if you are impaired or above blood-concentration limits, the card does not provide a defence.
• Pharmacy and travel queries: The card can facilitate pharmacist queries about your prescription status. For travel abroad with prescribed cannabis-based medicines, a separate Home Office personal licence under Regulation 37 of the Misuse of Drugs Regulations 2001 is required regardless of the card.
• Workplace disclosure: Some patients find the card useful when making occupational health disclosures, as it provides verifiable clinic contact details.

Contact Sapphire Medical directly to confirm current card issuance policy and how to request one after your prescription is issued.

Sapphire Access Scheme

Sapphire Medical operates an access scheme for patients who may face financial barriers to treatment. The Sapphire access scheme is designed to provide reduced-cost consultations and/or medication support for qualifying patients in financial hardship.

Eligibility for the access scheme is assessed on individual circumstances. Patients who may qualify include those on certain means-tested benefits, those facing severe financial hardship, or those in specific qualifying circumstances. Contact Sapphire directly before booking to enquire about access scheme eligibility and the documentation required — availability may vary by time of year and patient volume.

This is distinct from the standard fee structure. The access scheme reflects Sapphire's research ethos: building a broadly representative patient registry requires accessible pricing for patients across income levels.

How the Sapphire Patient Process Works

1. Eligibility assessment: Complete Sapphire's detailed online screening process, which is more comprehensive than many other clinics given the research context.

2. Booking: Select an appointment with the appropriate specialist from Sapphire's clinical team.

3. Specialist consultation: A thorough assessment by a specialist clinician, typically lasting up to 60 minutes for an initial appointment. Sapphire's consultations are known for their clinical rigour.

4. Patient registry enrolment: Sapphire patients are invited to contribute their outcomes data to the UK Medical Cannabis Registry as part of ongoing research. Participation is voluntary.

5. Prescription and dispensing: Prescriptions are fulfilled by licensed UK pharmacies and delivered by post.

6. Ongoing follow-up: Regular follow-up appointments monitor clinical outcomes and contribute to Sapphire's research programme.

Sapphire Medical Consultation and Medication Costs

• Initial consultation: From £150 — higher than most competitors, reflecting the more comprehensive assessment and research infrastructure
• Follow-up appointments: Priced accordingly — verify current rates at the time of booking
• Monthly medication: £150 to £400 per month depending on product and dosing

Sapphire's higher entry cost reflects the depth of their clinical assessment and their investment in research infrastructure. For patients who want a particularly thorough initial evaluation, this may represent good value.

What to Prepare for Your Sapphire Consultation

• A detailed summary of your medical history relevant to your condition — Sapphire's assessment process is more comprehensive than most, so the more documentation the better
• A thorough treatment history: all medications and therapies tried, doses, duration, and clinical reasons for stopping or changing
• Specialist letters, discharge summaries, or hospital reports related to your condition
• Your current medication list with doses
• Any neurological or psychiatric reports if relevant to your condition

Sapphire's assessments are notably thorough. Patients with complex conditions or extensive treatment histories should allow sufficient time to gather supporting documentation before booking.

Locations and Coverage

Physical locations: Edinburgh. Online consultations available UK-wide to all patients.

Find other clinics available in your area via the UK locations guide.

Sapphire Medical Edinburgh — In-Person Clinic

Sapphire Medical Foundations is one of the few UK cannabis clinics with a physical clinic location in Scotland. The Edinburgh clinic serves patients from across Scotland who prefer an in-person assessment rather than a video consultation. For patients in Edinburgh, Glasgow, Aberdeen, and the wider Central Belt, Sapphire Edinburgh provides direct access to a specialist prescriber without requiring travel to London.

Patients in Scotland can also choose to be seen by Sapphire via video consultation if they prefer — the Edinburgh physical option is in addition to, not a replacement for, the online pathway. Appointment fees are the same whether in-person or online. All prescriptions from Sapphire Edinburgh are fulfilled by UK-licensed pharmacies and posted to your address.

Sapphire vs Lyphe vs Mamedica — Clinical Comparison

Sapphire is the recommended choice for patients with neurological or complex conditions — particularly epilepsy, multiple sclerosis, and paediatric cases — where the depth of clinical expertise and the longer assessment time are clinically important. For common conditions such as chronic pain or PTSD where speed and cost are the priority, Lyphe or Mamedica may be faster and less expensive initially.

Sapphire Medical — Full Cost Breakdown (2026)

Sapphire's higher consultation and follow-up fees reflect the longer, more comprehensive assessment and the research infrastructure involved. Medication costs are broadly similar across all UK clinics as the same licensed products are available from the same UK pharmacies. For patients where clinical depth matters more than upfront cost, Sapphire's pricing is aligned with the service offered. See the full UK cost breakdown.

Frequently Asked Questions — Sapphire Medical UK

Is Sapphire Medical a legitimate and registered UK clinic?

Yes. Sapphire Medical Foundations works with GMC-registered specialist clinicians and operates within the UK legal framework for Schedule 2 cannabis-based medicines. They run the UK Medical Cannabis Registry in collaboration with academic partners — making them one of the most transparently verified clinics in the UK market. You can verify any prescriber at gmc-uk.org.

What is the UK Medical Cannabis Registry?

The UK Medical Cannabis Registry is an observational research programme collecting real-world outcomes data from patients prescribed cannabis-based medicines. Sapphire patients are invited to contribute their anonymised data voluntarily, helping build the UK evidence base. Participation does not affect your clinical care.

Why is Sapphire's consultation fee higher than other clinics?

Sapphire's higher fee reflects a more comprehensive initial assessment (45 to 60 minutes versus 30 to 45 minutes at most other clinics), the research infrastructure involved in running the patient registry, and a clinical team with significant academic and NHS credentials.

Is Sapphire suitable for children with epilepsy?

Sapphire has experience with paediatric cannabis prescribing, including for rare epilepsy syndromes such as Dravet and Lennox-Gastaut. This requires additional specialist involvement and is assessed on an individual clinical basis.

Does Sapphire have NHS links?

Sapphire has collaborated with NHS clinicians and academic institutions in research contexts. However, consultations at Sapphire are privately funded and separate from NHS pathways.

How long does the Sapphire assessment typically take?

Initial consultations at Sapphire typically last 45 to 60 minutes, longer than the average for UK cannabis clinics, reflecting the comprehensiveness of their assessment process.

Does Sapphire Medical have an access scheme?

Yes. Sapphire operates an access scheme for patients facing financial hardship, offering reduced-cost consultations and/or medication support. Contact Sapphire directly before booking to enquire about eligibility and what documentation is required.

Who is eligible to be seen at Sapphire Medical?

UK residents aged 18 and over (with paediatric exceptions for certain epilepsy syndromes) who have a confirmed diagnosis and can evidence that at least two conventional treatments have been tried without adequate benefit. Specialist letters from NHS consultants significantly strengthen eligibility assessments at Sapphire.

What conditions does Sapphire Medical treat?

Sapphire covers a broad range of conditions including chronic pain, multiple sclerosis, epilepsy, PTSD, anxiety, sleep disorders, cancer-related symptoms, Tourette syndrome, migraines, cluster headaches, and endometriosis. They have particular strength in neurological conditions and complex presentations.